Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ADAR1 and ADAR2 Expression in the Thoracic Aortic Wall Correlates with Aneurysm Severity and Dissection Risk: Insights into A-to-I RNA Editing Dysregulation in Marfan Syndrome-Derived vSMCs. | Int J Mol Sci | 2026 | 42794678 | PubTator, text mining | PubMed |
| Dynamic reprogramming and A-to-I RNA editing in neutrophils in response to tumor induction. | J Biol Chem | 2026 | 42754162 | PubTator, text mining | PubMed |
| Context-dependent modulation of the TAK1-MAPK axis by ginsenoside-based formulations along the NAFLD-HCC continuum. | J Ginseng Res | 2026 | 42718885 | PubTator, text mining | PubMed |
| A-to-I editing modifies the target and role of miR-376a-3p in papillary thyroid cancer. | 3 Biotech | 2026 | 42688527 | PubTator, text mining | PubMed |
| ADAR-mediated RNA editing in CNS disorders: from pathogenic mechanisms to therapeutic opportunities. | Cell Mol Biol Lett | 2026 | 42576199 | PubTator, text mining | PubMed |
| New insight into RNA biomarkers in neuropathic pain: a clinician-neuroscientist roadmap to translational testing and treatment monitoring a clinical review. | Front Pain Res (Lausanne) | 2026 | 42534835 | PubTator, text mining | PubMed |
| A contextual activity score (CAS) for inferring ADAR-associated transcriptional activity across RNA-seq, single-cell, and spatial transcriptomics. | Comput Methods Programs Biomed | 2026 | 42526067 | PubTator, text mining | PubMed |
| A reduction in A-to-I RNA editing by ADAR disrupts Pumilio-mediated inhibition of MAPK signaling to drive intestinal stem cell aging. | Sci Signal | 2026 | 42520108 | PubTator, text mining | PubMed |
| ADAR2-Mediated RNA Editing Promotes TDP-43 Nuclear Export and Alters RNA Binding. | bioRxiv | 2026 | 42395430 | PubTator, text mining | PubMed |
| The regulatory mechanism and clinical significance of RNA editing in prostate cancer. | Curr Urol | 2026 | 42368672 | PubTator, text mining | PubMed |
| RNA structure programs endogenous ADAR for precise and efficient editing. | Cell | 2026 | 42269608 | PubTator, text mining | PubMed |
| dsRADAR: Imaging and Quantifying Cellular dsRNA by Repurposing RNA Binding Proteins. | bioRxiv | 2026 | 42182131 | PubTator, text mining | PubMed |
| Mechanisms coordinating exit from the stem cell state in mammals. | Genes Dev | 2026 | 42156139 | PubTator, text mining | PubMed |
| Identification of plasma exosomal VPS41 chr7:38764322A>I editing as a diagnostic biomarker in lung cancer via a pan-cancer screen. | Respir Res | 2026 | 42121172 | PubTator, text mining | PubMed |
| ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability. | Nucleic Acids Res | 2026 | 42033221 | PubTator, text mining | PubMed |
| Novel CuCLIP-seq for in situ covalently captured protein-binding RNAs. | Nat Commun | 2026 | 42031762 | PubTator, text mining | PubMed |
| Cross-Cohort Evidence of Editome Dysregulation and Cell Growth-Related IGFBP7 Recoding Driven by ADARB1 in Fuchs Endothelial Corneal Dystrophy. | Invest Ophthalmol Vis Sci | 2026 | 42017307 | PubTator, text mining | PubMed |
| ADAR2 induces the differentiation of osteosarcoma cells by editing activity on IGFBP7: new implications for therapy. | Bone Res | 2026 | 41927527 | PubTator, text mining | PubMed |
| Trisomy 21 Drives ADARB1 Overexpression and Premature RNA Recoding in the Developing Fetal Brain. | Nat Commun | 2026 | 41917044 | PubTator, text mining | PubMed |
| Molecular Context of ADAR-Mediated Editing of Coding RNA in Colorectal and Lung Cancers. | Int J Mol Sci | 2026 | 41898488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers